Apollomics, Inc. Announces Initiation of SPARTA Phase 2 Clinical Trial for c-MET Inhibitor APL-101

    NEXT STORY
    Global Hospital Cleaning Chemicals Market Forecast to Grow by $ 2.96 Billion during 2020-2024. Progressing at a CAGR of 9%
    PREV STORY
    Apellis Announces Plans to Submit NDA for Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    CytomX Therapeutics Announces Pricing of Public Offering of Common Stock

    SOUTH SAN FRANCISCO, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...

    author_avatar
    NASDAQ Market News

    INVENTIVA : New results on lanifibranor to be presented at the International Liver Congress 2019

    New results on lanifibranor to be presented at the International Liver Congress 2019 New study ...

    author_avatar
    NASDAQ Market News

    Aptose Announces Appointment of Carol Ashe to Board of Directors

    SAN DIEGO and TORONTO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: ...

    author_avatar
    NASDAQ Market News